Free Trial
NASDAQ:HCAT

Health Catalyst Q3 2026 Earnings Date & Estimates

Health Catalyst logo
$1.74 -0.01 (-0.57%)
Closing price 04:00 PM Eastern
Extended Trading
$1.73 -0.01 (-0.57%)
As of 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Health Catalyst is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. The conference call is scheduled for 5:00 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
5:00 PM ET

What Analysts Expect from Health Catalyst in Q3 2026

Health Catalyst is expected to post earnings of -$0.02 per share on revenue of $55.38 million. In the same quarter a year earlier Health Catalyst reported $0.06 per share on revenue of $76.32 million. Health Catalyst last reported on August 6, 2026, posting $0.04 per share and beating the $0.0299 consensus estimate. Health Catalyst has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.02
Expected Revenue
$55.38 million
Prior-Year EPS
$0.06
Prior-Year Revenue
$76.32 million
Expected EPS Growth
-133.3%
Expected Revenue Growth
-27.4%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.04 (Beat by +$0.0101)
Last Quarter Revenue
$70.49 million
EPS Beat Rate
6 of last 8 quarters

Health Catalyst Q3 2026 Earnings FAQ

Health Catalyst (NASDAQ:HCAT) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Health Catalyst's Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Health Catalyst to post earnings of -$0.02 per share for Q3 2026.

The consensus revenue estimate for Health Catalyst is $55.38 million for Q3 2026.

Health Catalyst Earnings Headlines

Analyzing Health Catalyst (NASDAQ:HCAT) & GoodRx (NASDAQ:GDRX)
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
See More Health Catalyst Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Health Catalyst? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Health Catalyst and other key companies, straight to your email.

About Health Catalyst

Health Catalyst (NASDAQ:HCAT) provides data and analytics technology and services for healthcare organizations. Its solutions are designed to help hospitals, health systems and other providers organize clinical, operational and financial data, identify opportunities for improvement, and support more informed decisions.

The company’s offerings include its Health Catalyst Data Operating System, which integrates and manages healthcare data from multiple sources, along with analytics applications, artificial intelligence and machine-learning capabilities, and tools for population health, quality improvement, cost management and operational performance. Health Catalyst also provides implementation, consulting and ongoing support services to help customers apply analytics to clinical and business initiatives.

Founded in 2008, Health Catalyst primarily serves healthcare organizations in the United States. Dan Burton serves as the company’s chief executive officer, and Health Catalyst’s common stock trades on the Nasdaq under the symbol HCAT.

View Health Catalyst Profile